Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
172.76
-8.41 (-4.64%)
At close: Apr 10, 2026, 4:00 PM EDT
174.74
+1.98 (1.15%)
After-hours: Apr 10, 2026, 4:17 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.8 billion as of April 10, 2026. Its market cap has increased by 222.85% in one year.
Market Cap
6.80B
Enterprise Value
6.30B
1-Year Change
222.85%
Ranking
Category
Stock Price
$172.76
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.80B, an increase of 4,601.03%. That is a compound annual growth rate of 165.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 6.80B | 13.26% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 8.22B |
| Cytokinetics | 7.96B |
| Halozyme Therapeutics | 7.95B |
| ImmunityBio | 7.72B |
| Krystal Biotech | 7.60B |
| Kymera Therapeutics | 7.13B |
| Arcellx | 6.74B |
| Protagonist Therapeutics | 6.64B |